Objective We aimed to asses if there are differences in the clinical presentation and immune response of repeat as compared with initial syphilis.
Methods Prospective study: we prospectively recruited all patients with a new diagnosis of syphilis and tested their plasma for a range of cytochemokines and rapid plasma reagin (RPR) at baseline pretreatment and 6 months following therapy. Retrospective study: we compared RPR assay response kinetics between initial and repeat syphilis in persons attending our HIV/STI clinic from 1993 to 2016.
Results Prospective study: a total of 91 individuals, 36 with initial syphilis and 55 with repeat syphilis, were included in the study. At baseline visit, those with initial syphilis were more likely to be symptomatic and have higher levels of interleukin-10 than repeaters. At baseline, median RPR titres were higher in the repeat than the initial infection groups. Repeaters were less likely than those with initial infections to serorevert to a negative RPR and be serofast (<4-fold RPR titre decline) at 6 months.
Retrospective study: syphilis was diagnosed in 1027/43 870 individuals tested. At diagnosis, repeaters had higher RPR titres and a stepwise increase in RPR titre with number of syphilis episodes. They had a different RPR test response kinetic: they were less likely to be serofast and to serorevert than initial syphilis at 6 and 12 months. No individuals with four or more previous episodes of syphilis seroreverted.
Conclusion Repeat syphilis has a different clinical presentation and immunological response to initial infection.
- epidemiology (clinical)
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
CK and AT contributed equally.
Contributors CK conceptualised the study. CK and AT were responsible for the acquisition, analysis and interpretation of data. AT, CK, KO, TC, LK and MVE played a role in writing, editing and approving the final version.
Funding This work was part of Project ID: 757003 funded by the Flemish Government -Department of Economy, Science & Innovation.
Competing interests None declared.
Ethics approval Ethics Committee of the University Hospital Antwerp.
Provenance and peer review Not commissioned; externally peer reviewed.
Correction notice This paper has been amended since it was published Online First. The last author’s surname (Kesten) should be spelt Kestens. This has now been corrected.